GPT and neutropenia: Dose escalation to 350/75 resulted in two of six patients experiencing a DLT during cycle 1 (grade 3 increased alanine aminotransferase [ALT; n = 1]; grade 3 fatigue and grade 4 neutropenia for ≥7 days [n = 1]).